SymlinPen (AstraZeneca Pharmaceuticals LP)
Welcome to the PulseAid listing for the SymlinPen drug offered from AstraZeneca Pharmaceuticals LP. This Amylin Agonists [MoA],Amylin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | AstraZeneca Pharmaceuticals LP |
| NON-PROPRIETARY NAME: | pramlintide acetate |
| SUBSTANCE NAME: | PRAMLINTIDE ACETATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Amylin Agonists [MoA],Amylin Analog [EPC] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-01-08 |
| END MARKETING DATE: | 0000-00-00 |
SymlinPen HUMAN PRESCRIPTION DRUG Details:
| Item Description | SymlinPen from AstraZeneca Pharmaceuticals LP |
| LABELER NAME: | AstraZeneca Pharmaceuticals LP |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1000(ug/mL) |
| START MARKETING DATE: | 2015-01-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0310-6615_311dc8bf-5581-4ac4-9edd-7d4a16597dd4 |
| PRODUCT NDC: | 0310-6615 |
| APPLICATION NUMBER: | NDA021332 |
Other PRAMLINTIDE ACETATE Pharmaceutical Manufacturers / Labelers:
